Page 225 - Index

Mission-Critical Decisions, Made with Confidence.
48. Statement pursuant to details to be furnished for subsidiaries as prescribed by Companies
Act, 2013
As at and for the year ended December 31, 2024
Name of the entity Net Assets, i.e., total assets
minus total liabilities
Share in profit or loss Share in other
comprehensive income
Share in total comprehensive
income
As % of
consolidated
net assets
J lakh As % of
consolidated
profit or loss
J lakh As % of
consolidated
other
comprehensive
income
J lakh As % of
consolidated
total
comprehensive
income
J lakh
1 2 3 4 5 6 7 8 9
Financial Statements
Parent: Crisil Limited 69.4% 1,77,900 90.0% 61,588 90.3% 10,232 90.1% 71,820
Subsidiaries
Indian
1. Crisil Ratings Limited 7.8% 20,087 36.9% 25,265 0.0% -* 31.7% 25,265
2. Bridge to India Energy Private
Limited (Refer to note 45.1)
0.1% 147 0.1% 89 0.0% - 0.1% 89
3. Crisil ESG Ratings and
Analytics Limited (Refer to
note 45.2)
0.3% 821 -0.3% (236) 0.0% - -0.3% (236)
Foreign
1. Crisil Irevna Argentina S.A. 0.3% 654 0.3% 210 0.0% - 0.3% 210
2. Crisil Irevna Poland SP.Zo.o. 0.3% 846 0.3% 205 0.0% - 0.3% 205
3. Crisil Irevna UK Limited 24.9% 63,755 26.7% 18,278 0.0% - 22.9% 18,278
4. Crisil Irevna US LLC (Refer to
note 45.3)
9.5% 24,427 1.4% 981 0.0% - 1.2% 981
5. Crisil Irevna Information
Technology (Hangzhou) Co. Ltd.
0.3% 892 0.5% 345 0.0% - 0.4% 345
6. Coalition Development Limited 2.7% 6,944 22.6% 15,475 0.0% - 19.4% 15,475
7. Coalition Development
Singapore Pte Limited
0.2% 398 0.0% 31 0.0% - 0.0% 31
8. Greenwich Associates
Singapore PTE. LTD.
0.3% 686 0.2% 126 0.0% - 0.2% 126
9. Greenwich Associates Japan
K.K.
0.1% 207 0.0% 20 0.0% - 0.0% 20
10. Greenwich Associates UK
Limited
0.6% 1,656 0.1% 77 0.0% - 0.1% 77
11. Crisil Irevna Australia Pty Ltd 1.4% 3,686 0.4% 282 0.0% - 0.4% 282
12. Peter Lee Associates Pty.
Limited (Refer to note 45.4)
0.1% 260 0.3% 188 0.0% - 0.2% 188
13. Crisil Irevna Information
Technology Colombia SAS
(Refer to note 45.5)
0.0% 123 0.1% 47 0.0% - 0.1% 47
Total elimination/adjustment -18.3% (47,006) -79.7% (54,564) 9.7% 1,101 -67.0% (53,463)
TOTAL 100% 2,56,482 100% 68,407 100% 11,333 100% 79,740
Annual Report 2024
223